Ankylosing Spondylitis (AS)

16

Review clinical trials related to Ankylosing Spondylitis (AS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis

The purpose of this cross-sectional and comparative study is to investigate the impact of smartphone addiction on the cervical posture, musculoskeletal system, balance, and tongue pressure in individuals diagnosed with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS), and to compare these findings with a healthy control group. Smartphone addiction has become a major contributing factor to postural alterations such as Text Neck Syndrome. This study aims to evaluate and compare the Craniovertebral Angle (CVA), neck extensor muscle strength, Pressure Pain Thresholds (PPT) of the neck and shoulder, Single-Leg Stance (SLS) static balance, and tongue pressure among three distinct groups. A healthy control group will be included as a reference baseline to differentiate the postural and functional deterioration caused by rheumatological diseases from the additional mechanical load imposed by smartphone dependency. To eliminate the misleading effects of acute pain, joint swelling, and severe functional limitations during flare-ups, only patients with stable disease activity (DAS28 \< 3.2 for RA and BASDAI \< 4 for AS) will be enrolled. This approach aims to examine the pure biomechanical relationship between technological dependency and cervical functions, independent of active systemic inflammation.

Participants needed: 111
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Merve ŞahinUpdated: Jun 9, 2026Locations: 1
Eligibility criteria

Aged 18 to 65 years. [+4]

History of prior surgical intervention in the cervical region. [+7]

Status: Recruiting

Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis

Despite adequate control of disease activity with standard medical therapies, there remains an ongoing need for complementary and interventional approaches for the management of persistent back pain in patients with ankylosing spondylitis. Although the erector spinae plane block has been described in the literature as a safe and effective analgesic intervention for chronic back pain in various patient populations, to the best of our knowledge, no clinical study has specifically evaluated its use for persistent back pain in patients with ankylosing spondylitis receiving medical treatment. Therefore, the present study aims to evaluate the effects of erector spinae plane block on pain severity and clinical outcomes in patients with ankylosing spondylitis whose disease activity is controlled under treatment but who continue to experience persistent back pain.

Participants needed: 15
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Marmara UniversityUpdated: Jun 8, 2026Locations: 1
Eligibility criteria

Age between 18 and 65 years [+3]

Body mass index (BMI) greater than 35 kg/m² [+10]

Status: Recruiting

Oxidative Stress in Autoimmune Rheumatic Diseases

Rheumatic diseases constitute a group of non-communicable diseases characterized by chronic inflammation. The most common autoimmune rheumatic diseases (ARDs) are rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, myositis, Sjogren's syndrome and systemic scleroderma. These autoimmune disorders lead to joint destruction and adversely influence the human body systemically. One of their characteristics is comorbidity, since patients usually suffer also from other pathologies such as cardiovascular diseases and obesity. In addition, their treatment requires a combination of both biological and conventional pharmaceutical interventions as well as other parameters such as physical activity programs, nutrition, and the use of smart electronic devices. Therefore, the ARDs burden health systems worldwide. Apart from the physiological manifestations of ARDs, specific changes are observed at the cellular and molecular level. A common biochemical/molecular symptom of these diseases is oxidative stress. This condition leads to the disturbance of blood and tissue redox status due to the excessive production of free radicals. Given that free radicals are highly reactive moieties with strong oxidative capacity against biomolecules (i.e., proteins, lipids, DNA), they compromise the efficacy of the intrinsic antioxidant mechanisms and, finally, induce the disruption of redox homeostasis. However, there is no sufficient data linking the levels of redox status of patients with the progression of ARDs over time. Indeed, the onset and symptoms of ARDs are intertwined with the disruption of the patient redox homeostasis and the induction of oxidative stress. Concurrently, the absence of a completely effective pharmaceutical treatment emerges the need for the adoption of novel biomarkers for monitoring the severity of the symptoms and the evolution of ARDs in general. To that end, this study aims at first to investigate the blood redox status of patients with ARDs. Thus, specific redox biomarkers will be evaluated in the blood of patients in three time points (i.e., at Days 1, 180 and 360), and they will be associated with the clinical manifestations of their diseases. The ultimate goal is to clarify whether these biomarkers could putatively exert clinical significance, namely whether they could constitute an additional tool for the monitoring of the progression of these diseases in clinical practice.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of ThessalyUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Adult patients (>18 years old), with a primary diagnosis of rheumatoid arthritis... [+9]

Adult patients (>18 years old) with concurrent infectious disease [+2]

Status: Recruiting

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

This study is a multicenter, prospective cohort study designed to systematically evaluate the clinical efficacy of integrated Traditional Chinese and Western Medicine on short-term functional improvement in patients with ankylosing spondylitis, with the Bath Ankylosing Spondylitis Functional Index (BASFI) at 6 months of treatment as the primary outcome measure.

Participants needed: 790
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: China-Japan Friendship HospitalUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 20... [+2]

diagnosis of other autoimmune diseases besides the disease under investigation (... [+4]

Status: Recruiting

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.

Participants needed: 2,250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: China-Japan Friendship HospitalUpdated: Apr 13, 2026Locations: 1
Eligibility criteria

Patients aged 18 years or older [+1]

Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive... [+1]

Status: Recruiting

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).

Participants needed: 210
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: China-Japan Friendship HospitalUpdated: Apr 9, 2026Locations: 1
Eligibility criteria

fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 20... [+2]

diagnosis of other autoimmune diseases besides the disease under investigation (... [+4]

Status: Recruiting

Deep Breathing Combined With Core Stability Exercises in the Treatment of Patients With Ankylosing Spondylitis

Exercise may be considered the gold standard for the management of mechanical and functional symptoms associated with patients having AS and they are considered as a safe and effective treatment for improving strength, spinal mobility, and physical fitness in general. However, there were no definite types or doses recommended over others. Additionally, poor posture is one of the consequences of AS due to pain, loss of flexibility, and muscular weakness which may also affect respiratory function. This faulty mechanical posture of the thoracic and cervical spine may affect the pulmonary function of these patients. Therefore, the purpose of the current study is to investigate the efficacy of deep breathing exercises added to core stability exercises in the treatment of patients suffering from AS.

Participants needed: 30
Trial details
Age: 25-45Biological sex: AllType: InterventionalSponsor: Beni-Suef UniversityUpdated: Mar 9, 2026Locations: 1
Eligibility criteria

Receiving the same medical treatment [+4]

Presence of other systemic or neurological disorders [+1]

Status: Recruiting

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

The purpose of this study is to evaluate the safety and efficacy of secukinumab 300mg in Chinese adults participants with active ankylosing spondylitis (AS) who have had an inadequate response to at least 2 non-steroidal anti-inflammatory drugs (NSAIDs) or intolerance to or a contraindication for NSAIDs, and who are naïve to biologic disease-modifying anti-rheumatic drugs (bDMARD).

Participants needed: 100
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Tongji HospitalUpdated: Jan 27, 2026Locations: 3
Eligibility criteria

Participant with a clinical diagnosis of ankylosing spondylitis (AS) and meeting... [+5]

Prior exposure to any Janus kinase (JAK) inhibitor (including but not limited to... [+6]

Status: Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate. The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.

Participants needed: 10,000
Trial details
Age: 2+Biological sex: AllType: ObservationalSponsor: Brain Inflammation CollaborativeUpdated: Jan 22, 2026Locations: 1Duration: 10 Years
Eligibility criteria

Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgi... [+8]

Status: Not yet recruiting

The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis.

This study aimed to investigate the effects of high-intensity intermittent exercise and moderate-intensity continuous exercise on serum irisin levels, disease activity, functional status, and quality of life in patients with axial spondyloarthritis.

Participants needed: 75
Trial details
Age: 18-50Biological sex: AllType: InterventionalSponsor: Kirsehir Ahi Evran UniversitesiUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Patients diagnosed with axillary spondyloarthropathy according to ASAS diagnosti... [+7]

Those with uncontrolled cardiopulmonary disease (such as hypertension, chronic o... [+5]

Status: Not yet recruiting

The Effect of Laughter Yoga on Patients With Ankylosing Spondylitis

This study will be conducted to evaluate the effects of laughter yoga on disease activity, pain, functional status, depression/anxiety/stress, and quality of life in ankylosing spondylitis patients.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ataturk UniversityUpdated: Aug 17, 2025
Eligibility criteria

Those diagnosed with ankylosing spondylitis, [+6]

Patients who do not participate in laughter yoga [+1]

Status: Recruiting

The Relationship Between Arterial Stiffness and Pulmonary and Extrapulmonary Features in Ankylosing Spondylitis

The aim of this study was to investigate the relationship between arterial stiffness and pulmonary and extrapulmonary features in patients with ankylosing spondylitis.

Participants needed: 25
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Kirsehir Ahi Evran UniversitesiUpdated: Aug 12, 2025Locations: 1
Eligibility criteria

Diagnosis of ankylosing spondylitis according to ASAS diagnostic criteria [+3]

Having uncontrolled cardiopulmonary disease [+4]

Status: Recruiting

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

The purpose of the study is to verify the clinical feasibility of Benzathine penicillin (BPG) /Etanercept (ETN) combination regimen in patients with spondyloarthritis (SpA) and at the same time compare Benzathine penicillin /Etanercept combination regimen and Etanercept maintenance therapy in reducing disease activity, improving patients' clinical symptoms and body function scores, enhancing quality of life, improving imaging performance and safety.

Participants needed: 340
Trial details
Phase: Phase 4Age: 18-59Biological sex: AllType: InterventionalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Jun 26, 2025Locations: 6
Eligibility criteria

Not listed

Status: Recruiting

Bidirectional Cohort Study of Nanfang Spondyloarthritis

Spondyloarthritis(SpA) patients attending Nanfang Hospital of Southern Medical University will generate a large number of clinical condition scales, laboratory indicators, imaging data such as X-rays or MRIs in the course of multiple standardized follow-up visits, as well as medical specimens from some of the patients who undergo surgical treatments. The Department of Orthopaedic Surgery of Nanfang Hospital is looking forward to the future and proposes to establish a specialized cohort named "Nanfang SpA Bidirectional Specialized Disease Cohort" by simply recording the clinical and imaging data of the above patients who have attended the clinic, been treated routinely, and have been followed up in the department without any interventional research measures. The cohort is proposed to: (1) archive the disease characteristics, biochemical index data, and disease assessment scales of all SpA patients attending the Southern Hospital; (2) record the X-ray and magnetic resonance imaging data of the patients to establish the "Southern SpA Imaging Dataset". This provides strong support for subsequent SpA research projects and lays the foundation for subsequent large-scale transect studies and retrospective studies.

Participants needed: 3,000
Trial details
Age: 10-59Biological sex: AllType: ObservationalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: May 25, 2025Locations: 1Duration: 4 Years
Eligibility criteria

1.Attended Nanfang Hospital, Southern Medical University, 2010-2030 2.Prospectiv...

1. Women who are pregnant, preparing for pregnancy or breastfeeding 2.Moderate t...

Status: Not yet recruiting

A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Ankylosing spondylitis, radiographically negative axial spondyloarthritis, psoriatic arthritis, polymyalgia rheumatica, Takayasu arteritis, giant cell arteritis, non-ocular Behcet's disease, and enthesitis-related arthritis are common diseases in rheumatology. Traditional anti-rheumatic drugs are less effective and have greater side effects than biological agents. At present, there has been no large-scale registration study on rheumatic autoimmune diseases such as spondyloarthritis in China. However, data such as patient characteristics, medication patterns, and patient outcome reports of different rheumatology diseases can often serve as a reference for rheumatology clinicians to reasonably select treatment methods for different patients. Therefore, a large-scale registration study is needed to fill the gap in multi-disease registration studies in rheumatology departments in China.

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Jan 9, 2025Locations: 1
Eligibility criteria

Diagnosed with rheumatic autoimmune diseases such as ankylosing spondylitis/radi... [+3]

Status: Recruiting

Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis

A review of the literature did not identify any studies that assessed knowledge of cardiovascular disease risk factors and healthy lifestyle behaviours in patients with ankylosing spondylitis. The aim of this study is to assess knowledge of cardiovascular disease risk factors, healthy lifestyle behaviours and physical activity levels in patients with ankylosing spondylitis.

Participants needed: 42
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Kirsehir Ahi Evran UniversitesiUpdated: Oct 26, 2024Locations: 1Duration: 1 Day
Eligibility criteria

Diagnosis of ankylosing spondylitis according to ASAS diagnostic criteria [+3]

Having uncontrolled cardiopulmonary disease [+3]